FINANCING
Who is raising money: selling new shares, filing room to sell more later, or borrowing. New shares give every holder a smaller slice.
Shares soldSold over timeRoom to sell laterBorrowingReverse splitThe stock since the filing
Key
Shares soldSold over timeRoom to sell laterBorrowingReverse splitThe stock since the filing
Newest first. A company with several filings is one row; open it for each.
- BIAFbioAffinity Technologies, Inc.Public offeringsize not available−44.8%424B5 ↗
- GMMGlobal Mofy AI LimitedPublic offering, 45.0M sharessize not available+26.4%424B5 ↗
- ELOGEastern International Ltd.Registration for an offeringsize not available+134.7%F-1 ↗
- ENVXEnovix CorporationShelf$500.0M−60.6%S-3 ↗
- AQBAquaBounty Technologies, Inc.Notes$1.0M8.6% of value−27.2%8-K ↗
- VZVerizon Communications Inc.Notessize not available+3.9%424B3 ↗
- ABVCABVC BioPharma, Inc.Convertible notes$4.1M18% of value−13.4%8-K ↗
- ABVCABVC BioPharma, Inc.Private placement$3.4M15% of value−13.4%8-K ↗
- SUPNSupernus, Inc.Notes$650.0M11% of value−32.8%8-K ↗
- MSTRStrategy IncAt-the-market programme$21.00B64% of value−40.4%424B5 ↗
- MSTRStrategy IncAt-the-market programme$1.66B5.0% of value−40.4%424B5 ↗
- MSTRStrategy IncAt-the-market programme$2.10B6.4% of value−40.4%424B5 ↗
- MSTRStrategy IncAt-the-market programme$4.13B13% of value−40.4%424B5 ↗
- INDVIndivior Pharmaceuticals, Inc.Notes$650.0M+2.6%8-K ↗
- KEQUKewaunee Scientific CorporationUnregistered sale of shares, 8-K item 3.02size not available+0.3%8-K ↗
- INTZIntrusion Inc.Unregistered sale of shares, 8-K item 3.02size not available−54.3%8-K ↗
- ORCLOracle CorporationShelf, automatic (S-3ASR)no dollar limit−22.6%S-3ASR ↗
- BNZIBanzai International IncRegistration for an offeringsize not availableS-1 ↗
- BNZIBanzai International IncReverse split, 1-for-108-K ↗
- SHFSSHF Holdings, Inc.Unregistered sale of shares, 8-K item 3.02size not available−95.2%8-K ↗
- GEOThe GEO Group, Inc.Shelf, automatic (S-3ASR)no dollar limit+3.9%S-3ASR ↗
- RAPPRapport Therapeutics, Inc.Convertible notes, private placement and public offering$200.0M15% of value−7.5%
- RAPPRapport Therapeutics, Inc.Convertible notes$150.0M11% of value−7.5%8-K ↗
- RAPPRapport Therapeutics, Inc.Private placement, 1.43M shares$30.0M2.2% of value−7.5%8-K ↗
- RAPPRapport Therapeutics, Inc.Convertible notes$150.0M11% of value−4.3%424B5 ↗
- RAPPRapport Therapeutics, Inc.Public offering, 9.52M shares at $21.00$200.0M15% of value−4.3%424B5 ↗
- DINOHF Sinclair CorporationPrivate placement$257.0M1.7% of value−23.6%8-K ↗
- NXXTNextNRG, Inc.Reverse split, 1-for-10−70.7%8-K ↗
- ASPEAspen Neuroscience, Inc.Public offering, 9.38M shares at $15.00size not available424B4 ↗
- APVOAptevo Therapeutics Inc.At-the-market programme$2.3M1.6x value−69.8%424B5 ↗
- XELXcel Energy Inc.At-the-market programme, with Barclays Capital$6.00B12% of value−0.7%424B5 ↗
- ALLRAllarity Therapeutics, Inc.Public offeringsize not available−9.8%424B5 ↗
- EDBLEdible Garden AG IncorporatedUnregistered sale of shares, 8-K item 3.02size not available−40.8%8-K ↗
- BBTXBambusa Therapeutics, Inc.Public offering$168.9M21% of value424B4 ↗
- PLDPrologis, Inc.At-the-market programme, with BTIG$5.00B4.2% of value−4.3%424B5 ↗
- HSBCHSBC Holdings plcNotessize not available−7.1%424B5 ↗
- OPNWOpenWorld, Inc.Registered direct offering$3.5M47% of value424B5 ↗
- OPNWOpenWorld, Inc.Registered direct offering, 5.04M sharessize not available8-K ↗
- PTHSPelthos Therapeutics Inc.Private placement, 58K shares$57.5M2.3x value−61.4%8-K ↗
- VORVor Biopharma Inc.At-the-market programme, with William Blair$150.0M13% of value−8.2%424B5 ↗
- PLURPluri Inc.Private placement, 909K shares at $1.10size not available−21.7%8-K ↗
- RGENRepligen CorporationUnregistered sale of shares, 8-K item 3.02size not available−13.2%8-K ↗
- OLOXOlenox Industries Inc.Unregistered sale of shares, 8-K item 3.02size not available−31.2%8-K ↗
- DFNST3 Defense Inc.Private placement$10.0M1.8x value−66.9%8-K ↗
- HYFMHydrofarm Holdings Group, Inc.Registered direct offering, 1.60M shares at $0.905$1.4M22% of value−35.8%424B5 ↗
- PROKProKidney Corp.At-the-market programme$200.0M48% of value−29.3%8-K ↗
- PROKProKidney Corp.At-the-market programme, with Jefferies$200.0M48% of value−29.3%S-3 ↗
- PSECProspect Capital CorporationNotessize not available−21.6%424B5 ↗
- OFALOFA GroupUnregistered sale of shares, 8-K item 3.02size not available−31.6%8-K ↗